12/18/2007

Baxter Healthcare Corp. has received FDA approval to market its GelFoam Plus Hemostasis Kit, designed to control bleeding during surgical procedures. The kit features Baxter's human thrombin and Pfizer's GelFoam absorbable sponge.

Related Summaries